October 17, 2011 ISA Pharmaceuticals strengthens its Supervisory Board with the appointment of Professor Jan van de Winkel
October 5, 2011 FDA grants ISA Pharmaceuticals Orphan Drug Designation for the treatment of Vulvar Intraepithelial Neoplasia with its lead product ISA-HPV-SLP®
October 31, 2011 - November 2, 2011 BioEurope 2011: ISA will present, please contact us at info@isa-pharma.com for a meeting
For details on products and indications please click on the blue link in the chart.